In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Arbovirus Testing
... CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis ... Read More
-
Biochemistry Analyzers
... CAGR of 5.4% over the analysis period 2024-2030. Clinical Diagnostics Application, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.4 Billion by the end of the ... Read More
-
Blood Culture Tests
... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More
-
Carrier Screening
... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Cell Counting
... CAGR of 5.3% over the analysis period 2024-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end of the ... Read More
-
Cell Sorting
... CAGR of 9.2% over the analysis period 2024-2030. Cell Sorters, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis ... Read More
-
Laboratory Benchtop Automation
... at a CAGR of 4.8% over the analysis period 2024-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.7 Billion by ... Read More
-
Microfluidics
... 16.0% over the analysis period 2024-2030. Microfluidics Devices, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$63.5 Billion by the end of the analysis period. Growth ... Read More
-
In Vitro Diagnostics
... at a CAGR of 3.4% over the analysis period 2024-2030. IVD Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the ... Read More
-
Pneumonia Therapeutics
... CAGR of 6.7% over the analysis period 2024-2030. Pneumonia Drugs, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$6.8 Billion by the end of the analysis ... Read More
-
Western Blotting
... CAGR of 5.3% over the analysis period 2024-2030. Western Blotting Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Microbiology Culture
... CAGR of 3.8% over the analysis period 2024-2030. Eukaryotic Culture, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$5.2 Billion by the end of the analysis ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis ... Read More
-
Medical Device Market Medical Device Market by Device Type, Function, Durability, Therapeutic Segment, Risk Classification, Manufacture Method, Delivery/Acquisition, Operational Support Model, Connectivity and Region 2025 – 2030
... (hospital, home, clinic, etc.), function (critical care, diagnostic, dental, etc.), durability, risk classification, manufacturing method (traditional vs. 3D printed), delivery/acquisition method, operational support model, and connectivity (Bluetooth, cellular, Wi-Fi, etc.). It also examines the therapeutic ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 ... Read More
-
Thyroid Function Tests
... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing
... 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Ancestry & Relationship Testing, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$1.3 Billion ... Read More
-
Hemoglobin A1C (HbA1C) Testing
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC) Technology, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$714.5 Million by the end of the analysis ... Read More
-
First Aid Kits
... at a CAGR of 6.2% over the analysis period 2024-2030. Common Type Kit, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$189.1 Million by the end ... Read More
-
DNA Probes-Based Diagnostics
... at a CAGR of 9.4% over the analysis period 2024-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$20.4 Billion by the end ... Read More
-
Clinical Diagnostics Automation
... at a CAGR of 6.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 10.6% CAGR The Clinical Diagnostics Automation market in the U.S. ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More
-
Metabolic Testing Solutions
... at a CAGR of 6.8% over the analysis period 2024-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$324.1 Million by the end of ... Read More
Research Assistance
